Jean-François Chatal, MD, PhD.

Founder, Chief Medical Officer

Pioneer in nuclear medicine, former head of the nuclear medicine department at the University Hospital and the Nantes cancer center, professor emeritus of nuclear medicine at the University of Nantes, director of a cancerology and immunology research laboratory; founded ATLAB in 2008, sold to TELIX in 2018.


Sylvain Fanier, Msc. EMBA.


An entrepreneur with more than 30 years of experience in medical innovation, Sylvain has led several disruptive innovations from concept to global commercialization.


Patrick Breau, PharmD.

Qualified Person

Pharmaceutical experience in France and Africa for international laboratories, his career has covered all stages of the life cycle of a drug, from R&D, to production and packaging, as well as distribution/marketing.


Clément Mayeur, MS MBA.

Chief Financial Officer

Financial Director experienced in new technologies, media, biotech and medtech.


Sébastien Avila, PhD Eng, MBA.

Industrial and Information Systems Director

Engineer expert in industrial R&D of radiopharmaceutical technologies and solutions for nuclear medicine.


Blandine Nove-Josserand, PharmD.

Director of Pharmaceutical Affairs, DGD

Pharmacist expert in quality assurance, documentary systems and pharma and medtech regulatory and standards compliance.


Valentin Gillard, PharmD.

Director of Regulatory Affairs

Pharmacist specializing in pharmaceutical regulatory affairs for manufacturing and operating laboratories.


Stela Prapeau, MS Eng.

Quality Assurance Director

Quality Assurance Specialist Engineer, expert in the management of health quality systems.


Edwin Latouche, PharmD.

Production Director

Industrial pharmacist, expert in continuous improvement and pharmaceutical production flow optimization techniques.